About Us

Pharmaceuticals

Global Strategy

Kowa's pharmaceutical business is global, with offices in the United States, Europe and Asia. With a commitment to ground-breaking research, development and marketing, we ensure steady supply of products with quality and reliability to help people around the world enjoy better health.
Livalo® is a prescription drug for the treatment of dyslipidemia developed in Japan by Kowa and with its proven efficacy it has grown into our global product currently marketed in the United States and Asia.
Further launches are expected in Europe and other regions in the near future.

Kowa Research Europe Ltd.
Kowa Pharmaceutical Europe Co. Ltd.
Established in the UK in 1999, Kowa Research Europe Ltd. (KRE) administers and supervises clinical trials conducted in the European region within Kowa Company's global strategy for drug development.
Meanwhile, Kowa Pharmaceutical Europe Co. Ltd. (KPE) was established in 2000 and is in charge of marketing Kowa Company's products in Europe.
Kowa Research Institute, Inc.
Kowa Research Institute, Inc. (KRI) was established in 1997 and is now located in North Carolina. KRI is responsible for clinical development of Kowa Company's new drugs in the United States.
Kowa Pharmaceuticals America, Inc.
Established in 2008, Kowa Pharmaceuticals America, Inc. (KPA) focuses its efforts on sales & marketing, acquisition, development, and licensing of pharmaceutical products in the United States.
Kowa Science Institute
/Center for Interdisciplinary Cardiovascular Sciences
Kowa Science Institute/Center for Interdisciplinary Cardiovascular Sciences (KSI) is a joint research institution in which Kowa researchers and scientists from Brigham and Women's Hospital, an affiliate of Harvard Medical School, conduct joint research on discovery and development in the field of cardiometabolic diseases. Through this collaboration, we are continually strengthening our technological foundation and promoting pipeline research.
Kowa (Shanghai) Pharma Consulting Co., Ltd.
Established in 2007 in Shanghai, China, Kowa (Shanghai) Pharma Consulting Co., Ltd. (KSP) is responsible for drug promotion of Kowa Company's pharmaceutical products in the Chinese market.
Kowa Korea Company, Ltd.
Established in 2011 in Seoul,Kowa Korea Company, Ltd.(KKC) is responsible for sales promotion of Kowa Company's pharmaceutical products in the Korean market, and handles a variety of medical equipment / LED lighting fixtures / chemicals / industrial machinery / building-materials / fashion items, etc.
Kowa (Thailand) Co.,Ltd.
Established in 2013 in Bangkok, Thailand, Kowa (Thailand) Co.,Ltd. (KTC) is responsible for sales promotion of Kowa Company’s pharmaceutical products in Thailand market and handles a variety of medical equipment, LED lighting, chemicals, building materials, food, textile, and general merchandise.